Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cellsCristina Oliveras‐Ferraros, Javier A. Menéndez|British Journal of Cancer|2012Cited by 59